quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·1053d
SECFiling
TCR2 Therapeutics Inc. logo

SEC Form EFFECT filed by TCR2 Therapeutics Inc.

TCRR· TCR2 Therapeutics Inc.
Health Care
Original source

Companies

  • TCRR
    TCR2 Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 19UpdateGoldman$5.00
  • Jan 13UpdateHC Wainwright & Co.$19.00
  • Nov 19UpdatePiper Sandler$26.00
  • Nov 10UpdateSVB Leerink$7.00
  • Oct 21UpdateSVB Leerink$8.00
  • Sep 20UpdateTruist Securities$29.00

Related

  • INSIDER799d
    Tang Kevin C disposed of 4,394,800 shares (SEC Form 4)
  • 13D/G799d
    SEC Form SC 13G/A filed by TCR2 Therapeutics Inc. (Amendment)
  • SEC1047d
    SEC Form 15-12G filed by TCR2 Therapeutics Inc.
  • SEC1053d
    SEC Form EFFECT filed by TCR2 Therapeutics Inc.
  • SEC1053d
    SEC Form EFFECT filed by TCR2 Therapeutics Inc.
  • INSIDER1053d
    SEC Form 4 filed by Ubs Oncology Impact Fund L.P.
  • INSIDER1053d
    SEC Form 4 filed by Mpm Sunstates Fund, L.P.
  • INSIDER1053d
    SEC Form 4 filed by Mpm Bioventures 2014, L.P.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022